A boxed warning for testosterone on major adverse cardiovascular events is out and a new blood pressure warning is in, the ...

Hall scheduled an appointment with a specialist, and in 2024 started testosterone replacement therapy (TRT)—receiving regular ...

The FDA has recommended several labeling changes to all approved testosterone replacement therapy products based on the ...

Testosterone replacement therapy, which involves taking manufactured forms of testosterone, has surged in popularity. ...

Whether you played a sport in high school, college or even at the professional level, chances are you heard someone in a ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Medical experts reveal the often-missed signals of testosterone deficiency in men, from subtle mood changes to unexplained ...

The TRAVERSE trial, a large-scale clinical study with over 5,000 patients, published in 2023, concluded that TRT does not increase the risk of adverse cardiovascular outcomes in men with hypogonadism.

The FDA has announced new labeling changes for all testosterone products following a review of clinical trial data, including a TRAVERSE study and postmarket ambulatory blood pressure studies.

Discover strategies to maintain strength, mobility and energy as your body changes after 40, with expert advice on hormonal ...

Hypogonadism is a syndrome that affects both males and females. It’s associated with hormone deficiencies in the gonads ...